Keynote Financial Services LLC Takes $817,000 Position in Cigna Group $CI

Keynote Financial Services LLC bought a new stake in shares of Cigna Group (NYSE:CI) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 2,969 shares of the health services provider’s stock, valued at approximately $817,000.

Several other hedge funds also recently bought and sold shares of CI. Cary Street Partners Investment Advisory LLC grew its stake in shares of Cigna Group by 11.0% in the fourth quarter. Cary Street Partners Investment Advisory LLC now owns 363 shares of the health services provider’s stock valued at $100,000 after buying an additional 36 shares in the last quarter. OLD National Bancorp IN grew its stake in Cigna Group by 3.7% during the 4th quarter. OLD National Bancorp IN now owns 1,031 shares of the health services provider’s stock worth $284,000 after purchasing an additional 37 shares in the last quarter. CYBER HORNET ETFs LLC grew its stake in Cigna Group by 5.3% during the 4th quarter. CYBER HORNET ETFs LLC now owns 801 shares of the health services provider’s stock worth $220,000 after purchasing an additional 40 shares in the last quarter. BNP Paribas boosted its position in shares of Cigna Group by 0.7% during the 4th quarter. BNP Paribas now owns 5,676 shares of the health services provider’s stock worth $1,566,000 after acquiring an additional 40 shares in the last quarter. Finally, Cookson Peirce & Co. Inc. boosted its position in shares of Cigna Group by 0.8% during the 3rd quarter. Cookson Peirce & Co. Inc. now owns 4,953 shares of the health services provider’s stock worth $1,428,000 after acquiring an additional 41 shares in the last quarter. Institutional investors own 86.99% of the company’s stock.

Cigna Group Trading Up 1.0%

Shares of Cigna Group stock opened at $297.77 on Friday. Cigna Group has a fifty-two week low of $239.51 and a fifty-two week high of $338.89. The firm has a market cap of $78.77 billion, a PE ratio of 12.62, a P/E/G ratio of 1.14 and a beta of 0.28. The business’s fifty day moving average is $282.53 and its two-hundred day moving average is $278.01. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.69.

Cigna Group (NYSE:CI) last issued its earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, topping the consensus estimate of $7.60 by $0.19. The business had revenue of $68.52 billion for the quarter, compared to analyst estimates of $66.29 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The business’s quarterly revenue was up 4.6% on a year-over-year basis. During the same period last year, the company posted $6.74 EPS. Cigna Group has set its FY 2026 guidance at 30.350- EPS. Analysts anticipate that Cigna Group will post 30.39 earnings per share for the current year.

Cigna Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, June 18th. Investors of record on Thursday, June 4th will be given a $1.56 dividend. This represents a $6.24 annualized dividend and a dividend yield of 2.1%. The ex-dividend date of this dividend is Thursday, June 4th. Cigna Group’s dividend payout ratio (DPR) is 26.45%.

Insider Buying and Selling at Cigna Group

In other Cigna Group news, CEO David Cordani sold 201,878 shares of the firm’s stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total value of $59,113,915.96. Following the transaction, the chief executive officer directly owned 34,337 shares of the company’s stock, valued at $10,054,560.34. This trade represents a 85.46% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 0.60% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on the company. Piper Sandler reduced their target price on Cigna Group from $370.00 to $346.00 and set an “overweight” rating for the company in a report on Wednesday, June 3rd. Wells Fargo & Company upped their price objective on Cigna Group from $300.00 to $305.00 and gave the company an “equal weight” rating in a research note on Friday, May 1st. Sanford C. Bernstein boosted their target price on Cigna Group from $358.00 to $371.00 and gave the stock an “outperform” rating in a research report on Tuesday, May 5th. Truist Financial boosted their target price on Cigna Group from $320.00 to $350.00 and gave the stock a “buy” rating in a research report on Tuesday, February 17th. Finally, Mizuho upped their price target on Cigna Group from $330.00 to $340.00 and gave the stock an “outperform” rating in a report on Monday, June 8th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and six have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $338.80.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.